Disease Area Oncology, Novartis Institutes for Biomedical Research, Novartis, 4002, Basel, Switzerland.
Biozentrum, University of Basel, Spitalstrasse 41, 4056, Basel, Switzerland.
Sci Rep. 2022 Mar 23;12(1):4984. doi: 10.1038/s41598-022-09127-7.
The TEAD transcription factors are the most downstream elements of the Hippo pathway. Their transcriptional activity is modulated by different regulator proteins and by the palmitoylation/myristoylation of a specific cysteine residue. In this report, we show that a conserved lysine present in these transcription factors can also be acylated, probably following the intramolecular transfer of the acyl moiety from the cysteine. Using Scalloped (Sd), the Drosophila homolog of human TEAD, as a model, we designed a mutant protein (Glu352Gln) that is predominantly acylated on the lysine (Lys350). This protein binds in vitro to the three Sd regulators-Yki, Vg and Tgi-with a similar affinity as the wild type Sd, but it has a significantly higher thermal stability than Sd acylated on the cysteine. This mutant was also introduced in the endogenous locus of the sd gene in Drosophila using CRISPR/Cas9. Homozygous mutants reach adulthood, do not present obvious morphological defects and the mutant protein has both the same level of expression and localization as wild type Sd. This reveals that this mutant protein is both functional and able to control cell growth in a similar fashion as wild type Sd. Therefore, enhancing the lysine acylation of Sd has no detrimental effect on the Hippo pathway. However, we did observe a slight but significant increase of wing size in flies homozygous for the mutant protein suggesting that a higher acylation of the lysine affects the activity of the Hippo pathway. Altogether, our findings indicate that TEAD/Sd can be acylated either on a cysteine or on a lysine, and suggest that these two different forms may have similar properties in cells.
TEAD 转录因子是 Hippo 通路的最下游元件。它们的转录活性受到不同调节蛋白的调节,以及特定半胱氨酸残基的棕榈酰化/肉豆蔻酰化的调节。在本报告中,我们表明这些转录因子中存在的一个保守赖氨酸也可以被酰化,可能是通过酰基从半胱氨酸的分子内转移而来。使用果蝇 Sd(人类 TEAD 的同源物)作为模型,我们设计了一种突变蛋白(Glu352Gln),该蛋白主要在赖氨酸(Lys350)上被酰化。这种蛋白在体外与三个 Sd 调节因子-Yki、Vg 和 Tgi-结合的亲和力与野生型 Sd 相似,但与 Sd 上的半胱氨酸相比,其热稳定性显著提高。该突变蛋白也通过 CRISPR/Cas9 被引入果蝇的 sd 基因内源性位点。纯合突变体能够发育到成年期,没有明显的形态缺陷,并且突变蛋白的表达水平和定位与野生型 Sd 相同。这表明该突变蛋白既具有功能,又能够以与野生型 Sd 相似的方式控制细胞生长。因此,增强 Sd 的赖氨酸酰化对 Hippo 通路没有不利影响。然而,我们确实观察到携带突变蛋白的果蝇的翅膀大小略有但显著增加,这表明赖氨酸的更高酰化会影响 Hippo 通路的活性。总之,我们的发现表明 TEAD/Sd 可以在半胱氨酸或赖氨酸上被酰化,并且这两种不同形式可能在细胞中具有相似的性质。